About RegMedNet 

RegMedNet is a community site that unites the diverse regenerative medicine and advanced therapies community. Through partnership with our sister journal, Regenerative Medicine, we seek to educate and inspire to help this exciting field move forward at an even faster rate.  

On RegMedNet, you can find free educational webinars, expert opinion and insight, and exclusive peer-reviewed journal articles, as well as the latest news and advances. You can watch, listen and read about every step in the regenerative medicine and cell and gene therapy pipeline, from development, clinical trial and manufacture to regulation and commercialization, all in one place. 

 

About Regenerative Medicine 

Since 2006, Regenerative Medicine has been at the forefront of publishing the very best papers and reviews covering the entire regenerative medicine sector. The journal focusses on the entire spectrum of approaches to regenerative medicine, including small molecule drugs, biologics, biomaterials and tissue engineering, and cell and gene therapies, from discovery research, through to clinical development, through to commercialization.  

Regenerative Medicine provides a specialist forum to address the important challenges and advances in regenerative medicine, delivering this essential information in concise, clear and attractive article formats. The partnership with RegMedNet enables authors to present their research in the context of the current state of the industry, providing insight, expert insight and useful resources. 

Regenerative Medicine and RegMedNet together serve a rapidly growing, multidisciplinary and increasingly time-constrained community. We will continue to provide a critical overview of these advances as they progress, undergo clinical trials, and eventually become mainstream medicine. 

 

About Taylor & Francis 

Taylor & Francis supports diverse communities of experts, researchers and knowledge makers around the world to accelerate and maximize the impact of their work. We are a leader in our field, publish across all disciplines and have one of the largest Humanities and Social Sciences portfolios. Our expertise, built on an academic publishing heritage of over 200 years, advances trusted knowledge that fosters human progress.

Our 2,500+ people, based in a global network of offices in more than 15 countries, use their skills and the latest technology to curate, validate and share impactful advanced, emergent and applied knowledge. Under the Taylor & Francis, Routledge and F1000 imprints we publish 2,700 journals, 8,000 new books each year and partner with more than 700 scholarly societies.

Taylor & Francis is proud to be a Global Certified Accessible™ publisher and our operations and all our print publications are certified CarbonNeutral®.

The people behind RegMedNet

Meet the team
Megan Giboney
Editor
Felix Myhill
Assistant Editor
Georgia McNair
Senior Client Projects Manager
Jasmine Hagan
Journal Development Editor, Regenerative Medicine
Leela Ripton
Head of Digital and Marketing